Caucasian type 2 diabetic patients with microalbuminuria (MA) or overt nephropathy (ON) show greater heterogeneity of renal lesions than type 1 diabetic patients. We examined whether a similar situation exists in 30 Japanese type 2 diabetic patients [21 male, age 48 ± (SD) 8 years, known duration 11 ± (SD) 8 years] without definable renal disease other than diabetic nephropathy. Six patients were normoalbuminuric (NA), 11 MA, and 13 had ON. Normal controls were 9 age-matched Japanese living-related renal transplant donors. Electron microscopic morphometry was performed on renal biopsy specimens and related to renal function. Glomerular basement membrane width and mesangial fractional volume [Vv(Mes/glom)] were increased in all type 2 diabetic patients groups (NA, MA, ON) as compared with normal controls. The Vv(Mes/glom) correlated directly with urinary albumin/creatinine. However, Vv(Mes/glom) as well as glomerular basement membrane width overlapped among the three functional categories (NA, MA, ON) and normal controls. In conclusion: (1) similar to Caucasian type 2 diabetic patients, Japanese type 2 diabetic patients have greater heterogeneity of renal structure than Caucasian type 1 diabetic patients, and (2) urinary albumin is not a reliable indicator of underlying renal structure in Japanese type 2 diabetic patients.

Keywords:
Renal lesions, Diabetic nephropathy, Albuminuria
1.
USDRS 1996 Annual Data Report: Incidence and prevalence of ESRD. Am J Kidney Dis 1996;(suppl):34–47.
2.
Pugh JA, Medina RA, Cornell JC, Basu S: NIDDM is the major cause of diabetic end-stage renal disease: More evidence from a triethnic community. Diabetes 1995;44:1375–1380.
3.
Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 1984;78:785–794.
4.
Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143–1155.
5.
Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 1989;320:966–970.
6.
Fioretto P, Steffes MW, Mauer SM: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 1994;43:1358–1364.
7.
Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89–93.
8.
Viberti GC, Hil RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430–1432.
9.
Mathiesen ER, Oxenbøll B, Johansen K, Svenden PAA, Deckertt T: Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 1984;26:406–410.
10.
Lane PH, Steffes MW, Mauer SM: Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992;41:581–586.
11.
Parving HH, Gall MA, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41:758–762.
12.
Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996;39:1569–1576.
13.
Gambara V, Mecca G, Remuzzi G, Bertani T: Heterogenous nature or renal lesions in type II diabetes. J Am Soc Nephrol 1993;3:1458–1466.
14.
Hayashi H, Karasawa R, Inn H, Saitoh T, Ueno M, Nishi S, Suzuki Y, Ogino S, Maruyama Y, Kouda Y, Arakawa M: An electron microscopic study of glomeruli in Japanese patients with non-insulin-dependent diabetes mellitus. Kidney Int 1992;41:749–757.
15.
Inomata S, Oosawa Y, Itoh M, Inoue M, Masamune O: Analysis of urinary proteins in diabetes mellitus – with reference to the relationship between microalbuminuria and diabetic renal lesions. J Jpn Diabetes Soc 1987;30:429–435.
16.
Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996;7:930–937.
17.
Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P: Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000;49:476–484.
18.
Davis MD, Myers FL, Bresnick GH, de Venecia G: Natural evolution; in Current Diagnosis and Management of Chorioretinal Diseases. St. Louis, Mosby, 1979, pp 179–184.
19.
Fioretto P, Steffes MW, Sutherland DER, Mauer SM: Sequential renal biopsies in insulin-dependent diabetic patients: Structural factors associated with clinical progression. Kidney Int 1995;48:1929–1935.
20.
Jensen EB, Gundersen HJG, Østerby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 1979;115:19–33.
21.
Steffes MW, Bilous RW, Sutherland DER, Mauer SM: Cell and matrix components in the glomerular mesangium in type I diabetes. Diabetes 1992;41:679–684.
22.
Lane PH, Steffes WM, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993;43:661–667.
23.
Brito PL, Fioretto P, Drummond K, Kim Y, Steffes MW, Basgen JM, Sisson-Ross S, Mauer M: Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 1998;53:754–761.
24.
Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti GC, Østerby R: Glomerular structure in type 1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 1992;41:741–748.
25.
Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342–348.
26.
Fioretto P, Mauer M, Bortoloso E, Barzon I, Saller A, Dalla Vestra M, Abaterusso C, Baggio B, Nosadini R: Glomerular ultrastructure in type 2 diabetes (abstract). J Am Soc Nephrol 1998;9:114.
27.
Østerby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36:1064–1070.
28.
Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356–360.
29.
Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P: Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000;49:476–484.
30.
Christensen PK, Gall M-A, Parving H-H: Course of glomerular filtration rate in albuminuria type 2 diabetic patients with or without diabetic glomerulopathy. Diabetes Care 2000;23(suppl 2):B14–B20.
31.
Parving HH, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen F, Gall MA: Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis 1993;22:188–195.
32.
Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577–581.
33.
Schmitz A, Vaeth M: Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 1988;5:126–134.
34.
Marshall SM, Alberti CG, Mauer M: Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989;70:61–71.
35.
Caramori FL, Fioretto P, Mauer M: The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes 2000;49:1399–1408.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.